法国政府消息人士在周日指出，法国制药厂赛诺菲(Sanofi)已经达成协议，将旗下消费者健康部门Opella的控股权出售给美国私募股权公司CD&R(Clayton Dubilier & Rice)。消息人士指出，在赛诺菲、CD&R和法国政府三方进行 ...

Sanofi is increasing its R&D presence in China, announcing plans to open a global research hub focused on data analysis in Chengdu. The French firm said this confirms China as the “third pillar ...

The French government has taken a small stake in Sanofi's consumer healthcare business Opella, following political backlash ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes ...

Sanofi (EPA: SASY)(NASDAQ: SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier & Rice to sell a controlling stake in its consu ...

Hi, it’s Manuel Baigorri and Will Davies in Hong Kong, where Sebastian Fain and Kenneth I. Juster of Freshfields sat down to chat about how deals in Japan and India are offsetting the slowdown in ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. Sanofi has entered negotiations with private ...